Croatia
· Delayed Price · Currency is HRK · Price in EUR Medika d.d. Statistics
Total Valuation
Medika d.d. has a market cap or net worth of HRK 1.27 billion. The enterprise value is 1.57 billion.
| Market Cap | 1.27B |
| Enterprise Value | 1.57B |
Important Dates
The last earnings date was Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Medika d.d. has 28,954 shares outstanding.
| Current Share Class | 28,954 |
| Shares Outstanding | 28,954 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.44% |
| Owned by Institutions (%) | n/a |
| Float | 292 |
Valuation Ratios
The trailing PE ratio is 6.63.
| PE Ratio | 6.63 |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | 14.27 |
| P/OCF Ratio | 9.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.68, with an EV/FCF ratio of 17.71.
| EV / Earnings | 8.20 |
| EV / Sales | 0.21 |
| EV / EBITDA | 6.68 |
| EV / EBIT | 8.05 |
| EV / FCF | 17.71 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.14 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 2.35 |
| Debt / FCF | 6.11 |
| Interest Coverage | 10.45 |
Financial Efficiency
Return on equity (ROE) is 18.43% and return on invested capital (ROIC) is 7.71%.
| Return on Equity (ROE) | 18.43% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 7.71% |
| Return on Capital Employed (ROCE) | 14.64% |
| Revenue Per Employee | 7.12M |
| Profits Per Employee | 185,330 |
| Employee Count | 1,032 |
| Asset Turnover | 1.67 |
| Inventory Turnover | 8.22 |
Taxes
In the past 12 months, Medika d.d. has paid 42.42 million in taxes.
| Income Tax | 42.42M |
| Effective Tax Rate | 18.11% |
Stock Price Statistics
The stock price has decreased by -10.17% in the last 52 weeks. The beta is -0.15, so Medika d.d.'s price volatility has been lower than the market average.
| Beta (5Y) | -0.15 |
| 52-Week Price Change | -10.17% |
| 50-Day Moving Average | 5,051.00 |
| 200-Day Moving Average | 5,882.00 |
| Relative Strength Index (RSI) | 56.81 |
| Average Volume (20 Days) | 3 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medika d.d. had revenue of HRK 7.36 billion and earned 191.82 million in profits. Earnings per share was 6,624.88.
| Revenue | 7.36B |
| Gross Profit | 556.44M |
| Operating Income | 191.05M |
| Pretax Income | 234.24M |
| Net Income | 191.82M |
| EBITDA | 212.37M |
| EBIT | 191.05M |
| Earnings Per Share (EPS) | 6,624.88 |
Balance Sheet
The company has 237.06 million in cash and 543.03 million in debt, giving a net cash position of -305.98 million or -10,567.67 per share.
| Cash & Cash Equivalents | 237.06M |
| Total Debt | 543.03M |
| Net Cash | -305.98M |
| Net Cash Per Share | -10,567.67 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 39,320.97 |
| Working Capital | 486.35M |
Cash Flow
In the last 12 months, operating cash flow was 127.08 million and capital expenditures -38.25 million, giving a free cash flow of 88.84 million.
| Operating Cash Flow | 127.08M |
| Capital Expenditures | -38.25M |
| Free Cash Flow | 88.84M |
| FCF Per Share | 3,068.19 |
Margins
Gross margin is 7.56%, with operating and profit margins of 2.59% and 2.60%.
| Gross Margin | 7.56% |
| Operating Margin | 2.59% |
| Pretax Margin | 3.18% |
| Profit Margin | 2.60% |
| EBITDA Margin | 2.88% |
| EBIT Margin | 2.59% |
| FCF Margin | 1.21% |
Dividends & Yields
This stock pays an annual dividend of 1,652.69, which amounts to a dividend yield of 3.77%.
| Dividend Per Share | 1,652.69 |
| Dividend Yield | 3.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.00% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.77% |
| Earnings Yield | 15.13% |
| FCF Yield | 7.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medika d.d. has an Altman Z-Score of 2.32 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.32 |
| Piotroski F-Score | 6 |